top of page

Profile

Join date: Feb 25, 2020
Posts
Mar 2, 2020 ∙ 1 min
Gilead Sciences to buy Forty-Seven for $4.9B
Biopharmaceutical company Gilead Sciences to buy clinical-stage immuno-oncology company, Forty Seven, for $4.9B. “This agreement builds...
19
0
Feb 1, 2020 ∙ 5 min
Consolidation is Key for the Automotive Industry
The automotive industry is undergoing unprecedented changes on multiple fronts.
278
0
bottom of page